Catalyst Wire Dossier Catalyst Wire Dossier

68Ga-FAPI PET/MRI tracer

Gallium-68 fibroblast activation protein inhibitor
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-FAPI PET/MRI tracer, covering 2025-04-04 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma [Phase 1]

See pricing